三力制药
(603439)
| 流通市值：47.73亿 | | | 总市值：48.34亿 |
| 流通股本：4.04亿 | | | 总股本：4.09亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,038,498,412.06 | 701,831,013.39 | 408,589,489.7 | 2,144,385,836.12 |
| 营业收入 | 1,038,498,412.06 | 701,831,013.39 | 408,589,489.7 | 2,144,385,836.12 |
| 二、营业总成本 | 964,371,007.43 | 620,808,740.33 | 360,500,086.77 | 1,821,200,312.82 |
| 营业成本 | 325,518,798.86 | 227,979,815.51 | 140,343,699.8 | 649,987,094.24 |
| 税金及附加 | 14,226,070.1 | 9,740,268.06 | 5,880,519.84 | 24,692,811.31 |
| 销售费用 | 486,860,718.56 | 285,717,035.87 | 164,575,771.39 | 941,944,254.2 |
| 管理费用 | 113,041,719.36 | 75,774,631.59 | 39,832,633.64 | 147,412,607.7 |
| 研发费用 | 19,391,017.47 | 16,860,762.88 | 7,416,057.12 | 46,503,580.21 |
| 财务费用 | 5,332,683.08 | 4,736,226.42 | 2,451,404.98 | 10,659,965.16 |
| 其中:利息费用 | 7,159,495.15 | 6,654,547.47 | 3,115,907.42 | 14,612,712.92 |
| 其中:利息收入 | 1,882,555.43 | 1,380,764.73 | 1,305,104.54 | 3,988,287.47 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 199,659.21 | 110,145.21 | - | 145,081.52 |
| 加:投资收益 | -3,187,150.12 | 285,716.66 | 64,340.69 | 1,812,621.93 |
| 资产处置收益 | 92,041.7 | 92,043.74 | 175,528.98 | -172,440.9 |
| 资产减值损失(新) | -1,710,772.88 | -1,710,772.88 | -1,852,585.1 | -2,991,071.78 |
| 信用减值损失(新) | 8,878,739.62 | 3,598,062.64 | -1,113,235.95 | -10,230,274.92 |
| 其他收益 | 7,567,289.56 | 3,779,654.59 | 1,881,247.62 | 14,499,347.25 |
| 四、营业利润 | 85,967,211.72 | 87,177,123.02 | 47,244,699.17 | 326,248,786.4 |
| 加:营业外收入 | 6,872,222.38 | 6,864,429.41 | 702,261.32 | 1,922,315.2 |
| 减:营业外支出 | 185,996.67 | 131,901.57 | 47,449.61 | 3,145,708.86 |
| 五、利润总额 | 92,653,437.43 | 93,909,650.86 | 47,899,510.88 | 325,025,392.74 |
| 减:所得税费用 | 8,976,120.2 | 8,518,316.84 | 5,362,851.36 | 45,187,860.19 |
| 六、净利润 | 83,677,317.23 | 85,391,334.02 | 42,536,659.52 | 279,837,532.55 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 83,677,317.23 | 85,391,334.02 | 42,536,659.52 | 279,837,532.55 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 80,786,973.31 | 83,060,963.83 | 41,946,770.84 | 274,027,809.74 |
| 少数股东损益 | 2,890,343.92 | 2,330,370.19 | 589,888.68 | 5,809,722.81 |
| 扣除非经常损益后的净利润 | 66,428,551.43 | 70,982,107.8 | 38,582,237.18 | 267,971,194.03 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.2 | 0.2 | 0.1 | 0.67 |
| (二)稀释每股收益 | 0.2 | 0.2 | 0.1 | 0.67 |
| 九、综合收益总额 | 83,677,317.23 | 85,391,334.02 | 42,536,659.52 | 279,837,532.55 |
| 归属于母公司股东的综合收益总额 | 80,786,973.31 | 83,060,963.83 | 41,946,770.84 | 274,027,809.74 |
| 归属于少数股东的综合收益总额 | 2,890,343.92 | 2,330,370.19 | 589,888.68 | 5,809,722.81 |
| 公告日期 | 2025-10-28 | 2025-08-28 | 2025-04-23 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |